GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Denis Chem Lab Ltd (BOM:537536) » Definitions » Price-to-Owner-Earnings

Denis Chem Lab (BOM:537536) Price-to-Owner-Earnings : 20.48 (As of May. 23, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Denis Chem Lab Price-to-Owner-Earnings?

As of today (2024-05-23), Denis Chem Lab's share price is ₹178.15. Denis Chem Lab's Owner Earnings per Share (TTM) ended in Mar. 2023 was ₹8.70. It's Price-to-Owner-Earnings for today is 20.48.


The historical rank and industry rank for Denis Chem Lab's Price-to-Owner-Earnings or its related term are showing as below:

BOM:537536' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 5.45   Med: 8.88   Max: 29.13
Current: 21.79

During the past 11 years, the highest Price-to-Owner-Earnings of Denis Chem Lab was 29.13. The lowest was 5.45. And the median was 8.88.


BOM:537536's Price-to-Owner-Earnings is ranked better than
59.05% of 420 companies
in the Drug Manufacturers industry
Industry Median: 27.395 vs BOM:537536: 21.79

As of today (2024-05-23), Denis Chem Lab's share price is ₹178.15. Denis Chem Lab's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₹6.62. Therefore, Denis Chem Lab's PE Ratio for today is 26.91.

As of today (2024-05-23), Denis Chem Lab's share price is ₹178.15. Denis Chem Lab's EPS without NRI for the trailing twelve months (TTM) ended in was ₹7.67. Therefore, Denis Chem Lab's PE Ratio without NRI for today is 23.24.

During the past 11 years, Denis Chem Lab's highest PE Ratio without NRI was 536.64. The lowest was 0.84. And the median was 16.52.


Denis Chem Lab Price-to-Owner-Earnings Historical Data

The historical data trend for Denis Chem Lab's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Denis Chem Lab Price-to-Owner-Earnings Chart

Denis Chem Lab Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 5.41 16.31 8.39 7.33

Denis Chem Lab Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 7.33 - - -

Competitive Comparison of Denis Chem Lab's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Denis Chem Lab's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Denis Chem Lab's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Denis Chem Lab's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Denis Chem Lab's Price-to-Owner-Earnings falls into.



Denis Chem Lab Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Denis Chem Lab's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=178.15/8.70
=20.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Denis Chem Lab  (BOM:537536) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Denis Chem Lab Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Denis Chem Lab's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Denis Chem Lab (BOM:537536) Business Description

Traded in Other Exchanges
N/A
Address
Satellite Road, 401 Abhishree Complex, Opposite OM Tower, Beside Bidiwala Park, Ahmedabad, GJ, IND, 380015
Denis Chem Lab Ltd is a pharmaceutical company involved in the manufacturing of pharmaceutical products. The company offers sterile intravenous injectables for human and veterinary use for different therapeutic areas. Its product portfolio includes antibiotic injections, diuretic injections, parenteral amino acid injections, plasma volume expanders, anti-pyretic Inj. irrigation solutions and dialysis solutions. The company has only one reportable segment which is Manufacturing, and Sales of Transfusion Solution in Bottles It generates its revenues through the sale of transfusion solution in bottles.

Denis Chem Lab (BOM:537536) Headlines

No Headlines